PCV5 EPROSARTAN VERSUS OTHERANGIOTENSIN-RECEPTOR BLOCKERS COMMONLY USED IN POLAND (IRBESARTAN, LOSARTAN, TELMISARTAN AND VALSARTAN) IN PATIENTS WITH HYPERTENSION-DIRECT ANALYSIS
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65420-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)65420-4/fulltext
Title :
PCV5 EPROSARTAN VERSUS OTHERANGIOTENSIN-RECEPTOR BLOCKERS COMMONLY USED IN POLAND (IRBESARTAN, LOSARTAN, TELMISARTAN AND VALSARTAN) IN PATIENTS WITH HYPERTENSION-DIRECT ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65420-4&doi=10.1016/S1098-3015(10)65420-4
First page :
Section Title :
Open access? :
No
Section Order :
579